Home > Healthcare > Medical Devices > Medical Supplies > ultrasonic scalpel market
Get a free sample of Ultrasonic Scalpel Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Ultrasonic Scalpel Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Key players in the market focus on technological innovation to enhance device efficiency, precision, and safety. They invest in research and development to introduce ergonomic designs, improve energy efficiency, and integrate compatibility with robotic-assisted surgical systems. Companies also emphasize expanding their presence in emerging markets like Asia-Pacific through partnerships, local manufacturing, and affordable product offerings. Additionally, they prioritize strategic acquisitions to strengthen their product portfolios and distribution networks.
Prominent players operating in the ultrasonic scalpel industry include:
Key players in the industry include Anhui Wanyi Science and Technology, Apollo Technosystems, Axon Medical Solutions, Bioventus, BOWA Medical UK, Hangzhou Rex Medical Instrument, HENAN TRADING, Johnson and Johnson, Miconvey, Olympus, Reach Surgical, SI Surgical, and Stryker.
The North America ultrasonic scalpel market recorded USD 1.2 billion in revenue in 2024 and is projected to grow at a CAGR of 6.2% from 2025 to 2034, driven by the increasing prevalence of chronic diseases.
The handheld devices segment generated USD 1.3 billion in revenue in 2024, owing to their essential role in both open and minimally invasive surgeries.
The global ultrasonic scalpel industry was valued at USD 2.7 billion in 2024 and is expected to grow at a CAGR of 6.9% from 2025 to 2034, driven by the rising adoption of outpatient procedures and robotic-assisted surgeries.